Health Economics
Our Health Economics team operates out of offices in Oxford, Vancouver, Toronto, Morristown, New Jersey and San Francisco, and is led by:
- Neil Hawkins, Vice President, Health Economics
- Andrew Briggs, Senior Scientific Advisor
- Mark Sculpher, Senior Scientific Advisor
- David Scott , Senior Director, Health Economics
- John Schneider, Senior Director, Health Economics
- Les Noe, Vice President, Americas West
Our Senior Management team includes opinion-leading scientists with an extensive experience of international market access and reimbursement issues. They are supported by a knowledgeable and enthusiastic team of over 30 senior and junior scientists who provide a wealth of research and consulting expertise, covering the full spectrum of health technology appraisal methods.
Our in-company team is assisted by an extensive network of internationally-recognized opinion leaders, methodologists, as well as global and national market access and reimbursement experts. We have links with consultants and researchers at many agencies and universities around the world, including: University of Oxford, University of Glasgow, University of York, University of Sheffield, McMaster University, University of British Columbia and University of Washington. We work hard to integrate this diverse academic, commercial, and in-country expertise into our resource base. We cultivate these strong academic, commercial and clinical networks in order to maintain our knowledge of leading-edge science, as well as current regulatory and reimbursement affairs. For more about Oxford Outcomes’ affiliations and networks click here.
Within our Health Economics team we also have additional complementary specialist skills in:
- Infectious disease modeling (using dynamic modeling techniques)
- Evidence synthesis including network meta analysis
- Pricing research including value-based pricing
- Systematic review.
- Strategic market access consulting